Tevogen Bio Holdings Inc.

NASDAQ: TVGN · Healthcare · Biotechnology

PublicHQ Warren, NJ · WarrenCIK 0001860871Reports USD

#1 of 1,422 Healthcare companies by revenue

EA Score

——

FH 16DQ —GM —SS 34

v0.1 · 35/100 weight · pillars only

↑ market scale, workforce scale · ↓ return on assets, listing tenure

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$26.3M

Employees

as of 2026-08-21

Market cap

$26.5M

as of 2026-08-21

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$26.3M-$26.3M2025

Operating income-$26.1M-$26.1M2025

Total assets$4.4M$4.4M2025

Liabilities$12.6M$12.6M2025

Equity-$8.2M-$8.2M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Tevogen Bio Holdings Inc.’s financial profile?

Tevogen Bio Holdings Inc. earned -$26.3M in FY2025 net income.

Peers · Healthcare

Sernova Corp.——Sangamo Therapeutics, Inc.——HeartBeam, Inc.——Actuate Therapeutics Inc——NurExone Biologic Inc.——Quantum BioPharma Ltd.——

Neighbors

Warren →

PTC Therapeutics, Inc.$1.7B72B Aquestive Therapeutics, Inc.$44.5M47D OMID Holdings, Inc.$394.1k48D Edible Garden AG Incorporated$12.8M32D

Key facts

CEORyan H. Saadi

SectorHealthcare

IndustryBiotechnology

HeadquartersWarren, NJ

ExchangeNASDAQ: TVGN

Employees18

IPO date2022-01-05

Latest filings

8-K2026-08-26 10-Q2026-08-14 DEF 14A2026-08-03 8-K2026-07-30 10-Q2026-05-15 8-K2026-04-22 10-K2026-03-31 8-K2026-03-25

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.